# Thomas James > Thomas James is a seed investor at Phoebus Optoelectronics backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Phoebus Optoelectronics](https://shizune.co/investors/profile/phoebus-optoelectronics) - Total investments: 2 - Last investment: Mar 2019 - Lead investor: 0% - Last updated: Aug 2026 Thomas James is a seed investor at Phoebus Optoelectronics focused on Health Care and Biotechnology. Thomas James ## Round sizes | Stage | Round size | | --- | --- | | Seed | $52k–$1.9M | ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Health Care | 1 | 50% | | Biotechnology | 1 | 50% | | Health Diagnostics | 1 | 50% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Unima | Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking. | $1.9M | Seed | Mar 24, 2019 | | | Miproto | Miproto is changing manufacturing for both businesses and individuals. The website allows anybody to upload their product idea, and have it developed by the same engineers working on the worlds most advanced technologies, into 3D CAD files, 3D printed models, prototypes and even mass manufactured items.The company brings together the disjointedprocess into one slick system – reducing times from months to days and weeks. Whilst reducing costs by cutting admin roles and multiple projects managers across facilities.Miproto provides a platform for product design that connects in house engineers with a global army of 24/7 freelancers, client projects, CAD files, 3D printing machines, CNC factories, mass manufacturing facilities, and even a 2D printer for invoicing!Whilst Student, Joey McConnel, was able to develop his university project component into a manufactured piece, the Design Council used Miproto to design and 3D print 200 awards for the designers involved in the London 2012 Olympics. At the same time, top secret medical devices where being prototyped in the London 3D printers. These were being designed over night by a selection of client chosen freelance engineers, based in America and Asia. | $52K | Seed | Feb 15, 2013 | | 2 of 2 investments shown. ## Co-investors - [Avalancha Ventures](https://shizune.co/investors/profile/avalancha-ventures) — VC Fund, 1 deal together - [Dadneo](https://shizune.co/investors/profile/dadneos) — VC Fund, 1 deal together - [Venturance Alternative Assets](https://shizune.co/investors/profile/fondo-alerce-venture-capital) — VC Fund, 1 deal together - [Fondo Vulcano](https://shizune.co/investors/profile/fondo-vulcano) — VC Fund, 1 deal together - [Genesis Capital Ventures](https://shizune.co/investors/profile/genesis-capital-venture) — VC Fund, 1 deal together - [Investo](https://shizune.co/investors/profile/investomex) — VC Fund, 1 deal together ## About Phoebus Optoelectronics VC Fund 1 contacts available at Phoebus Optoelectronics. | Name | Title | Profile | | --- | --- | --- | | Thomas James | Principal | https://shizune.co/investors/profile/thomas-james | ## Similar investors ### Similar industry - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Galaxy Interactive](https://shizune.co/investors/profile/galaxy-interactive) — VC Fund - [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ### Similar country - [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund - [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund - [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund ## Featured in investor lists - [Biotechnology Angel Investors in LATAM](https://shizune.co/investors/biotechnology-angel-investors-latam) - [Biotechnology Angel Investors in Mexico](https://shizune.co/investors/biotechnology-angel-investors-mexico) - [Biotech Angel Investors in LATAM](https://shizune.co/investors/biotech-angel-investors-latam) - [Biotech Investors in Mexico](https://shizune.co/investors/biotech-investors-mexico) - [Manufacturing Angel Investors in United Kingdom](https://shizune.co/investors/manufacturing-angel-investors-united-kingdom) - [Art Investors in United Kingdom](https://shizune.co/investors/art-investors-united-kingdom) ## FAQ ### What does Thomas James invest in? Thomas James invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Mexico. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### What is Thomas James's check size? Thomas James typically joins rounds of $52k–$1.9M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Thomas James participates in. ### When did Thomas James last invest? The most recent investment recorded for Thomas James closed in Mar 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co